Increased Serum Inhibin B Levels In Postmenopausal Women With Altered Thyroid Function

Abstract

Hyper- and hypothyroidism have significant effects on the female reproductive system. However, little in the way of data is available on the relationship between ovarian paracrine control and thyroid function. This study was aimed at characterising the serum levels of inhibin B in relation to altered thyroid function. Serum inhibin B and FSH levels were measured in 91 women (51 regularly cycling and 40 postmenopausal). The mean serum concentration of inhibin B in euthyroid cycling women (0.025 ± 0.018 µg/l) was similar to that observed in hyper- and hypothyroid patients (0.022 ± 0.015 and 0.018 ± 0.014 µg/l, respectively, p = ns). Inhibin B levels were obviously reduced (- 72 %) in euthyroid postmenopausal women. In contrast, in hyper- and hypothyroid postmenopausal women, inhibin B levels remained substantially at the premenopausal level. So far, serum inhibin B appeared to be significantly increased in both hyperthyroid patients (0.025 ± 0.014 µg/l; p < 0.0001) and in hypothyroid patients (0.016 ± 0.006 µg/l; p = 0.0006). Altered thyroid function did not affect FSH levels at fertile age. However, a significant decrease of FSH levels was observed in hyper- and hypothyroid (- 52 % and - 43 %, respectively) postmenopausal women. Nevertheless, these FSH levels remained in the postmenopausal range. These results indicate that an altered thyroid function affects serum inhibin B levels in postmenopausal women.

Inhibin B - Menopause - Hyperthyroidism - Hypothyroidism

References

• 1 Krassas G E. Thyroid disease and female reproduction.  Fertil Steril. 2000;  74 1063-1070
• 2 Vale W, Hsueh A, Rivier C, Yu J. The inhibin/activin family of hormones and growth factors. In: Sporn MB, Roberts AB (ed) Handbook of Experimental Pharmacology. Heidelberg; Springer-Verlag 1990: 211-248
• 3 Pezzani I, Reis F M, di Leonardo C, Luisi S, Santuz M, Driul L, Cobellis L, Petraglia F. Influence of non-gonadotrophic hormones on gonadal function.  Mol Cell Endocrinol. 2000;  161 37-42
• 4 Magoffin D A, Jakimiuk A J. Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women.  Hum Reprod. 1997;  12 1714-1719
• 5 Kingsley D M. The TGF-β superfamily: new members, new receptors and new genetic test of function in different organisms.  Gene Dev. 1994;  8 133-146
• 6 Franzen A, Piek E, Westermark B, ten Dijke P, Heldin N E. Expression of transforming growth factor-beta 1, activin A and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.  Endocrinology. 1999;  140 4300-4310
• 7 Schulte K M, Jonas C, Krebs R, Roher H D. Activin A and activin receptors in the human thyroid: a link to the female predominance of goiter?.  Horm Metab Res. 2000;  32 90-400
• 8 Morpurgo P, Corsi A, Corbetta S, Vicentini L, Spada A. In vitro release of activin A from human normal and pathological thyroid tissues.  J Endocrinol Invest. 2001;  24 RC25-27
• 9 Harada K, Shintani Y, Sakamoto Y, Wakatsuki M, Shitsukawa K, Saito S. Serum immunoreactive activin A levels in normal subjects and patients with various diseases.  J Clin Endocrinol Metab. 1996;  81 2125-2130
• 10 Centanni M, Viceconti N, Luisi S, Reis F, Gargano L, Maiani F, Franchi A, Canettieri G, Petraglia F. Reversible increase of serum activin A levels in women with Graves’ disease.  J Endocrinol Invest. 2002;  25 967-970
• 11 Burger H G. The endocrinology of the menopause.  J Steroid Biochem and Mol Biol. 1999;  69 31-35
• 12 Soules M R, Battaglia D E, Klein N A. Inhibin and reproductive aging in women.  Maturitas. 1998;  30 193-204
• 13 Bukman A, Heineman M J. Ovarian reserve testing and the use of prognostic models in patients with subfertility.  Human Reprod Update. 2001;  6 581-590
• 14 Tamura K, Hatsuta M, Watanabe G, Taya K, Kogo H. Inhibitory regulation of inhibin gene expression by thyroid hormone during ovarian development in immature rats.  Biochem Biophys Res Comm. 1998;  242 102-108
• 15 Groome N P, Illingworth P J, O’Brien M, Cooke I, Ganesan T S, Baird D T, McNeilly A S. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay.  Clin Endocrinol. 1994;  40 717-723
• 16 Groome N P, Illingworth P J, O’Brien M, Pai R, Rodger F E, Mather J P, McNeilly A S. Measurement of dimeric inhibin B throughout the human menstrual cycle.  J Clin Endocrinol Metab. 1996;  81 1401-1405
• 17 Robertson D M, Stephenson T, Pruysers E, McCloud P, Tsigos A, Groome N P, Mamers P, Burger H H. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.  J Clin Endocrinol Metab. 2002;  87 816-824
• 18 Zhang S, Carrillo A J, Darling D S. Expression of multiple thyroid hormone receptor mRNAs in human oocytes, cumulus cells and granulosa cells.  Mol Hum Reprod. 1997;  3 555-562
• 19 Meunier H, Rivier C, Evans R M, Vale W. Gonadal and extragonadal expression of inhibin α- and β-subunits in various tissues predicts diverse functions.  Proc of Natl Acad Sci. 1988;  85 247-251
• 20 Mason A J. Structure and recombinant expression of human inhibin and activin. In: Hogden GD, Rosenwacs Z, Spieler JM (ed) Nonsteroidal gonadal factors: physiological roles and possibilities in contraceptive development. Norfolk; Jones Institute 1988: 19-35
• 21 Roberts V J, Barth S, El Roeiy A, Yen S SC. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle.  J Clin Endocrinol Metab. 1993;  77 1402-1410
• 22 Burger H G. Evidence for a negative feedback role of inhibin in follicle stimulating hormone regulation in women.  Hum Reprod. 1993;  8 129-132